Does the hepatic branch of vagus mediate the secretion of glucagon-like peptide-1 during the Roux-en-Y gastric bypass surgery?

J Gastrointest Surg. 2014 Nov;18(11):1957-64. doi: 10.1007/s11605-014-2632-z. Epub 2014 Sep 3.

Abstract

Objectives: The purpose of this study is to investigate the impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass (RYGB) on the level of fasting and postprandial serum glucagon-like peptide-1 (GLP-1) in type 2 diabetic mellitus rats.

Methods: Randomized block design, factorial experiment. Forty-five type 2 diabetic rats were divided into four groups: sham operation (S, n = 10) and sham operation with the hepatic branch of the vagotomy (SV, n = 11), Roux-en-Y gastric bypass (RYGB, n = 12) and RYGB without preservation of the vagus (RYGBV, n = 12). Levels of fasting and postprandial serum GLP-1 30 min after 50 % glucose solution (2 g/kg) by gavage were determined before surgery and postoperatively at 1, 4, and 8 weeks. Interactions between RYGB and the common hepatic branch were also assessed.

Results: Roux-en-Y gastric bypass surgery significantly increased the concentration of postprandial serum GLP-1 and maintained it at a higher level (P < 0.05). Preservation of vagus hepatic branch only increased the concentration of postprandial serum GLP-1 at the initial stage (P < 0.05), which gradually weakened over time (P > 0.05). Both RYGB and vagotomy of the hepatic branch had no influence on fasting serum GLP-1 (P > 0.05).

Conclusions: During RYGB surgery for the long-term treatment of T2DM, preservation of the hepatic branch of the vagus might have no impact on serum GLP-1 level.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Analysis of Variance
  • Anastomosis, Roux-en-Y / methods
  • Animals
  • Blood Glucose / analysis
  • Body Weight
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / surgery
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / surgery*
  • Disease Models, Animal
  • Gastric Bypass / methods*
  • Glucagon-Like Peptide 1 / metabolism*
  • Insulin Resistance
  • Liver / innervation
  • Male
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Reference Values
  • Streptozocin
  • Survival Rate
  • Treatment Outcome
  • Vagotomy*
  • Vagus Nerve / surgery*

Substances

  • Blood Glucose
  • Streptozocin
  • Glucagon-Like Peptide 1